Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge.

Duperret EK, Perales-Puchalt A, Stoltz R, G H H, Mandloi N, Barlow J, Chaudhuri A, Sardesai NY, Weiner DB.

Cancer Immunol Res. 2019 Feb;7(2):174-182. doi: 10.1158/2326-6066.CIR-18-0283. Epub 2019 Jan 24.

PMID:
30679156
2.

Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti-CTLA-4 Antibodies Induces Tumor Shrinkage In Vivo.

Duperret EK, Trautz A, Stoltz R, Patel A, Wise MC, Perales-Puchalt A, Smith T, Broderick KE, Masteller E, Kim JJ, Humeau L, Muthumani K, Weiner DB.

Cancer Res. 2018 Nov 15;78(22):6363-6370. doi: 10.1158/0008-5472.CAN-18-1429. Epub 2018 Oct 4.

PMID:
30287678
3.

A Designer Cross-reactive DNA Immunotherapeutic Vaccine that Targets Multiple MAGE-A Family Members Simultaneously for Cancer Therapy.

Duperret EK, Liu S, Paik M, Trautz A, Stoltz R, Liu X, Ze K, Perales-Puchalt A, Reed C, Yan J, Xu X, Weiner DB.

Clin Cancer Res. 2018 Dec 1;24(23):6015-6027. doi: 10.1158/1078-0432.CCR-18-1013. Epub 2018 Sep 27.

PMID:
30262507
4.

Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study.

Sivapalasingam S, Kamal M, Slim R, Hosain R, Shao W, Stoltz R, Yen J, Pologe LG, Cao Y, Partridge M, Sumner G, Lipsich L.

Lancet Infect Dis. 2018 Aug;18(8):884-893. doi: 10.1016/S1473-3099(18)30397-9. Epub 2018 Jun 18.

PMID:
29929783
5.

CK-2127107 amplifies skeletal muscle response to nerve activation in humans.

Andrews JA, Miller TM, Vijayakumar V, Stoltz R, James JK, Meng L, Wolff AA, Malik FI.

Muscle Nerve. 2018 May;57(5):729-734. doi: 10.1002/mus.26017. Epub 2017 Dec 11.

PMID:
29150952
6.

Posttraumatic Stress Disorder, Depression, and Other Comorbidities: Clinical and Systems Approaches to Diagnostic Uncertainties.

Colston MJ, Belsher BE, Beech EH, Curry JC, Tyberg YA, Melmed AZ, McGraw KL, Stoltz RF.

Fed Pract. 2016 Nov;33(11):37-45.

PMID:
30766149
7.

A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers.

Laties A, Rich CC, Stoltz R, Humbert V, Brickman C, McVicar W, Baumgartner RA.

J Ocul Pharmacol Ther. 2016 Oct;32(8):548-554. Epub 2016 Apr 5.

8.

The Absolute Bioavailability and Effect of Food on the Pharmacokinetics of Odanacatib: A Stable-Label i.v./Oral Study in Healthy Postmenopausal Women.

Zajic S, Rossenu S, Hreniuk D, Kesisoglou F, McCrea J, Liu F, Sun L, Witter R, Gauthier D, Helmy R, Joss D, Ni T, Stoltz R, Stone J, Stoch SA.

Drug Metab Dispos. 2016 Sep;44(9):1450-8. doi: 10.1124/dmd.116.069906. Epub 2016 Jul 11.

PMID:
27402726
9.

Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction study.

Spyker DA, Cassella JV, Stoltz RR, Yeung PP.

Pharmacol Res Perspect. 2015 Dec 17;3(6):e00194. doi: 10.1002/prp2.194. eCollection 2015 Dec.

10.

Neonatal Abstinence Syndrome: The Experience of Infant Massage.

Hahn J, Lengerich A, Byrd R, Stoltz R, Hench J, Byrd S, Ford C.

Creat Nurs. 2016 Feb 1;22(1):45-50. doi: 10.1891/1078-4535.22.1.45.

PMID:
30188305
11.

Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib.

Jin Y, Smith CL, Hu L, Campanale KM, Stoltz R, Huffman LG Jr, McNearney TA, Yang XY, Ackermann BL, Dean R, Regev A, Landschulz W.

Clin Pharmacol Ther. 2016 Mar;99(3):274-84. doi: 10.1002/cpt.260. Epub 2015 Nov 25.

PMID:
26351780
12.

Racial Disparities in Child Adversity in the U.S.: Interactions With Family Immigration History and Income.

Slopen N, Shonkoff JP, Albert MA, Yoshikawa H, Jacobs A, Stoltz R, Williams DR.

Am J Prev Med. 2016 Jan;50(1):47-56. doi: 10.1016/j.amepre.2015.06.013. Epub 2015 Sep 2.

PMID:
26342634
13.

Effect of ceralifimod (ONO-4641) on lymphocytes and cardiac function: Randomized, double-blind, placebo-controlled trial with an open-label fingolimod arm.

Krösser S, Wolna P, Fischer TZ, Boschert U, Stoltz R, Zhou M, Darpo B.

J Clin Pharmacol. 2015 Sep;55(9):1051-60. doi: 10.1002/jcph.513. Epub 2015 May 25.

PMID:
25855155
14.

Results from the IQ-CSRC prospective study support replacement of the thorough QT study by QT assessment in the early clinical phase.

Darpo B, Benson C, Dota C, Ferber G, Garnett C, Green CL, Jarugula V, Johannesen L, Keirns J, Krudys K, Liu J, Ortemann-Renon C, Riley S, Sarapa N, Smith B, Stoltz RR, Zhou M, Stockbridge N.

Clin Pharmacol Ther. 2015 Apr;97(4):326-35. doi: 10.1002/cpt.60.

PMID:
25670536
15.

Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human.

Rorick-Kehn LM, Witcher JW, Lowe SL, Gonzales CR, Weller MA, Bell RL, Hart JC, Need AB, McKinzie JH, Statnick MA, Suico JG, McKinzie DL, Tauscher-Wisniewski S, Mitch CH, Stoltz RR, Wong CJ.

Int J Neuropsychopharmacol. 2014 Oct 31;18(2). pii: pyu036. doi: 10.1093/ijnp/pyu036.

16.

A thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonist.

Hoch M, Darpo B, Remenova T, Stoltz R, Zhou M, Kaufmann P, Bruderer S, Dingemanse J.

Drug Des Devel Ther. 2014 Dec 17;9:175-85. doi: 10.2147/DDDT.S75565. eCollection 2015.

17.

Does the type of sleep surface influence infant wellbeing in the NICU?

Stoltz R, Byrd R, Hench AJ, Slone T, Brockopp D, Moe K.

MCN Am J Matern Child Nurs. 2014 Nov-Dec;39(6):363-8. doi: 10.1097/NMC.0000000000000078.

PMID:
25333803
18.

Effect of ponesimod, a selective S1P1 receptor modulator, on the QT interval in healthy individuals.

Hoch M, Darpo B, Brossard P, Zhou M, Stoltz R, Dingemanse J.

Basic Clin Pharmacol Toxicol. 2015 May;116(5):429-37. doi: 10.1111/bcpt.12336. Epub 2014 Nov 8.

19.

Development and evaluation of cesarean section surgical training using computer-enhanced visual learning.

York SL, Maizels M, Cohen E, Stoltz RS, Jamil A, McGaghie WC, Gossett DR.

Med Teach. 2014 Nov;36(11):958-64. doi: 10.3109/0142159X.2014.917156. Epub 2014 Jul 29.

PMID:
25072410
20.

Tirasemtiv amplifies skeletal muscle response to nerve activation in humans.

Hansen R, Saikali KG, Chou W, Russell AJ, Chen MM, Vijayakumar V, Stoltz RR, Baudry S, Enoka RM, Morgans DJ, Wolff AA, Malik FI.

Muscle Nerve. 2014 Dec;50(6):925-31. doi: 10.1002/mus.24239.

21.

Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects.

Lowe SL, Wong CJ, Witcher J, Gonzales CR, Dickinson GL, Bell RL, Rorick-Kehn L, Weller M, Stoltz RR, Royalty J, Tauscher-Wisniewski S.

J Clin Pharmacol. 2014 Sep;54(9):968-78. doi: 10.1002/jcph.286. Epub 2014 Mar 26.

PMID:
24619932
22.

Editorial: the mental health of our deploying generation.

Stoltz RF.

MSMR. 2013 Jul;20(7):2-3. No abstract available.

PMID:
23927057
23.

Utilization of computer enhanced visual learning (CEVL) method improves endoscopic diagnosis of posterior urethral valves (PUV).

Matoka DJ, Marks AJ, Stoltz RS, Maizels M.

J Pediatr Urol. 2013 Aug;9(4):498-502. doi: 10.1016/j.jpurol.2012.07.019. Epub 2012 Sep 12.

PMID:
22981142
24.

Computer-Enhanced Visual Learning Method to Teach Endoscopic Correction of Vesicoureteral Reflux: An Invitation to Residency Training Programs to Utilize the CEVL Method.

Bauschard M, Maizels M, Kirsch A, Koyle M, Chaviano T, Liu D, Stoltz RS, Maizels E, Prasad M, Marks A, Bolnick D.

Adv Urol. 2012;2012:831384. doi: 10.1155/2012/831384. Epub 2012 Jan 9.

25.

Effectiveness of the computer enhanced visual learning method in teaching the society for fetal urology hydronephrosis grading system for urology trainees.

Marks A, Maizels M, Mickelson J, Yerkes E, Anthony Herndon CD, Lane J, Ben-Ami T, Maizels E, Stoltz RS, Dixon S, Liu D, Chaviano T, Hagerty J, Kaplan W.

J Pediatr Urol. 2011 Apr;7(2):113-7. doi: 10.1016/j.jpurol.2010.09.009. Epub 2010 Nov 20.

PMID:
21094626
26.

Computer enhanced visual learning method to train urology residents in pediatric orchiopexy provided a consistent learning experience in a multi-institutional trial.

McQuiston L, Macneily A, Liu D, Mickelson J, Yerkes E, Chaviano A, Roth D, Stoltz RS, Herz DB, Maizels M.

J Urol. 2010 Oct;184(4 Suppl):1748-53. doi: 10.1016/j.juro.2010.03.072. Epub 2010 Aug 21.

PMID:
20728179
27.

Residency training in neonatal circumcision: a pilot study and needs assessment.

Le B, Mickelson J, Gossett D, Kim D, Stoltz RS, York S, Sharma V, Maizels M.

J Urol. 2010 Oct;184(4 Suppl):1754-7. doi: 10.1016/j.juro.2010.03.077. Epub 2010 Aug 21.

PMID:
20728165
28.

Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study.

Hussey EK, Dobbins RL, Stoltz RR, Stockman NL, O'Connor-Semmes RL, Kapur A, Murray SC, Layko D, Nunez DJ.

J Clin Pharmacol. 2010 Jun;50(6):636-46. doi: 10.1177/0091270009352185. Epub 2010 Mar 3.

PMID:
20200268
29.

A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects.

Bloomfield DM, Krishna R, Hreniuk D, Hickey L, Ghosh K, Bergman AJ, Miller J, Gutierrez MJ, Stoltz R, Gottesdiener KM, Herman GA, Wagner JA.

J Clin Pharmacol. 2009 Aug;49(8):937-46. doi: 10.1177/0091270009337511.

PMID:
19602719
30.

Metabolic disposition of [14C]bazedoxifene in healthy postmenopausal women.

Chandrasekaran A, McKeand WE, Sullivan P, DeMaio W, Stoltz R, Scatina J.

Drug Metab Dispos. 2009 Jun;37(6):1219-25. doi: 10.1124/dmd.108.023861. Epub 2009 Mar 9.

PMID:
19273530
31.

Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron.

Adams LM, Johnson B, Zhang K, Yue L, Kirby LC, Lebowitz P, Stoltz R.

Support Care Cancer. 2009 Sep;17(9):1187-93. doi: 10.1007/s00520-008-0572-4. Epub 2009 Feb 10.

32.

Minimal pharmacokinetic interaction between the human immunodeficiency virus nonnucleoside reverse transcriptase inhibitor etravirine and the integrase inhibitor raltegravir in healthy subjects.

Anderson MS, Kakuda TN, Hanley W, Miller J, Kost JT, Stoltz R, Wenning LA, Stone JA, Hoetelmans RM, Wagner JA, Iwamoto M.

Antimicrob Agents Chemother. 2008 Dec;52(12):4228-32. doi: 10.1128/AAC.00487-08. Epub 2008 Oct 6.

33.

Integrating bright futures into medical education and training.

Stoltz RA, Connors K, Blum J, Bernstein HH.

Pediatr Ann. 2008 Apr;37(4):244-51. No abstract available.

PMID:
18488982
34.

Effect of aspirin therapy on photodynamic therapy with verteporfin for choroidal neovascularization.

Ranchod TM, Guercio JR, Ying GS, Brucker AJ, Stoltz RA.

Retina. 2008 May;28(5):711-6. doi: 10.1097/IAE.0b013e31816079c3.

PMID:
18463514
35.

Effects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers.

Sansone-Parsons A, Krishna G, Simon J, Soni P, Kantesaria B, Herron J, Stoltz R.

Antimicrob Agents Chemother. 2007 Feb;51(2):495-502. Epub 2006 Nov 13.

36.
37.

A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.

Gupta AK, Leonardi C, Stoltz RR, Pierce PF, Conetta B; Ravuconazole onychomycosis group.

J Eur Acad Dermatol Venereol. 2005 Jul;19(4):437-43.

PMID:
15987289
38.

Transmission of retinal laser wavelengths through blood.

Stoltz RA, Glazer-Hockstein C, Tolentino MJ, Maguire AM.

Retina. 2005 Jun;25(4):498-502.

PMID:
15933598
39.

Pharmacokinetics, metabolism and excretion of intravenous [l4C]-palonosetron in healthy human volunteers.

Stoltz R, Parisi S, Shah A, Macciocchi A.

Biopharm Drug Dispos. 2004 Nov;25(8):329-37.

PMID:
15378559
40.

Parecoxib sodium demonstrates gastrointestinal safety comparable to placebo in healthy subjects.

Harris SI, Stoltz RR, LeComte D, Hubbard RC.

J Clin Gastroenterol. 2004 Aug;38(7):575-80.

PMID:
15232360
41.

Assessing the learning needs of maternal and child health professionals to teach health promotion.

Bernstein HH, Rieber S, Stoltz RA, Shapiro DE, Connors KM.

Matern Child Health J. 2004 Jun;8(2):87-93.

PMID:
15198176
42.
43.

A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.

Musselman DM, Ford AP, Gennevois DJ, Harbison ML, Laurent AL, Mokatrin AS, Stoltz RR, Blue DR.

BJU Int. 2004 Jan;93(1):78-83.

PMID:
14678373
44.

Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.

Olden K, DeGarmo RG, Jhingran P, Bagby B, Decker C, Markowitz M, Carter E, Bobbitt W, Dahdul A, DeCastro E, Gringeri L, Johanson J, Levinson L, Mula G, Poleynard G, Stoltz RR, Truesdale R, Young D; Lotronex Investigator Team.

Am J Gastroenterol. 2002 Dec;97(12):3139-46.

PMID:
12492201
45.

Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects.

Stoltz RR, Harris SI, Kuss ME, LeComte D, Talwalker S, Dhadda S, Hubbard RC.

Am J Gastroenterol. 2002 Jan;97(1):65-71.

PMID:
11808971
46.
47.

Pharmacokinetics of single-dose oral stavudine in subjects with renal impairment and in subjects requiring hemodialysis.

Grasela DM, Stoltz RR, Barry M, Bone M, Mangold B, O'Grady P, Raymond R, Haworth SJ.

Antimicrob Agents Chemother. 2000 Aug;44(8):2149-53.

48.

Pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses in healthy volunteers.

Viegas TX, Omura GA, Stoltz RR, Kisicki J.

J Clin Pharmacol. 2000 Apr;40(4):410-20. Erratum in: J Clin Pharmacol 2000 Jun;40(6):664.

PMID:
10761169
49.

Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia.

Stein E, Isaacsohn J, Stoltz R, Mazzu A, Liu MC, Lane C, Heller AH.

Am J Cardiol. 1999 May 15;83(10):1433-6.

PMID:
10335757
50.

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study.

Goldstein DJ, Wang O, Saper JR, Stoltz R, Silberstein SD, Mathew NT.

Cephalalgia. 1997 Nov;17(7):785-90.

PMID:
9399010

Supplemental Content

Loading ...
Support Center